| Pharmaceutical Information |
| Drug Name |
Levodopa-4'-monophosphate |
| Drug ID |
BADD_D01274 |
| Description |
Foslevodopa is under investigation in clinical trial NCT04750226 (Study to Assess Adverse Events and Change in Disease Activity of 24-hour Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Advanced Parkinson's Disease). |
| Indications and Usage |
Not Available |
| Marketing Status |
Discontinued |
| ATC Code |
N04BA01 |
| DrugBank ID |
DB16683
|
| KEGG ID |
D00059
|
| MeSH ID |
D007980
|
| PubChem ID |
127766
|
| TTD Drug ID |
DP7GK8
|
| NDC Product Code |
Not Available |
| Synonyms |
Levodopa | L-Dopa | L Dopa | 3-Hydroxy-L-tyrosine | 3 Hydroxy L tyrosine | L-3,4-Dihydroxyphenylalanine | L 3,4 Dihydroxyphenylalanine | Levopa | Larodopa | Dopaflex | Dopar |
|
| Chemical Information |
| Molecular Formula |
C9H12NO7P |
| CAS Registry Number |
97321-87-4 |
| SMILES |
C1=CC(=C(C=C1CC(C(=O)O)N)O)OP(=O)(O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
|
|
| ADRs Induced by Drug |
|
|
